Paying for Prescription Drugs in the New Administration.

Kesselheim, Aaron S; Hwang, Thomas J; Avorn, Jerry

Kesselheim, Aaron S; Hwang, Thomas J; Avorn, Jerry.

Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Hwang TJ; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Avorn J; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

JAMA ; 325(9): 819-820, 2021 03 02.

Article in English | MEDLINE | ID: covidwho-1147006

Subject(s)

Drug Costs/legislation & jurisprudence; Prescription Drugs/economics; Prescription Fees/legislation & jurisprudence; Humans; Legislation, Drug; Medicare/legislation & jurisprudence; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prescription Fees / Drug Costs / Prescription Drugs Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google